Trials / Unknown
UnknownNCT01284439
Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma
Effect of Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% in the Treatment of Ocular Surface Disease in Glaucoma Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To study effect of hydroxypropylmethylcellulose 0.3% and sodium hyaluronate 0.18% in the treatment of ocular surface disease in glaucoma patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hydroxypropylmethylcellulose | TearA: QID to every 2 hous , 1-2 drops per each time , duration 1 month |
| DRUG | sodium hyaluronate | QID to every 2 hous, 1-2 drops per each time, duration 1 month |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-01-01
- Completion
- 2012-02-01
- First posted
- 2011-01-27
- Last updated
- 2011-01-27
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01284439. Inclusion in this directory is not an endorsement.